Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
|Slideshows|April 14, 2017
6 Key Questions When You Suspect Melancholia
Author(s)Gordon Parker, MD, PhD, DSc, FRANZCP
Most depressed people acknowledge impaired concentration and other related symptoms-but skilled clinicians can distinguish between non-melancholic depression and melancholia. How? They ask the right questions.
Advertisement
View the slides in PDF format.
Advertisement
Related to this article
Ketamine, esketamine, and ECT can rapidly ease suicidal thoughts, but evidence for preventing attempts or deaths remains limited—see what’s proven.
Helus Pharma advances oral deuterated psilocin HLP003 for MDD, detailing new efficacy and safety analyses plus ongoing phase 3 PARADIGM trial updates.
Advertisement
Advertisement